Education
About Us
Working with TipRanks
Follow Us
Aura Biosciences Inc (AURA)
NASDAQ:AURA
Total Valuation
Aura Biosciences Inc has a market cap or net worth of $352.84M. The enterprise value is $203.98M.
Market Cap$352.84M
Enterprise Value$203.98M
Share Statistics
Aura Biosciences Inc has 62,119,873 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding62,119,873
Owned by Insiders3.35%
Owned by Institutions57.90%
Financial Efficiency
Aura Biosciences Inc’s return on equity (ROE) is -0.57 and return on invested capital (ROIC) is -56.37%.
Return on Equity (ROE)-0.57
Return on Assets (ROA)-0.48
Return on Invested Capital (ROIC)-56.37%
Return on Capital Employed (ROCE)-0.57
Revenue Per Employee0.00
Profits Per Employee-819.99K
Employee Count106
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Aura Biosciences Inc is ―. Aura Biosciences Inc’s PEG ratio is 0.50.
PE Ratio―
PS Ratio0.00
PB Ratio2.69
Price to Fair Value2.69
Price to FCF-5.03
Price to Operating Cash Flow-3.77
PEG Ratio0.50
Income Statement
In the last 12 months, Aura Biosciences Inc had revenue of 0.00 and earned -86.92M in profits. Earnings per share was -1.75.
Revenue0.00
Gross Profit0.00
Operating Income-96.12M
Pretax Income-86.81M
Net Income-86.92M
EBITDA-94.89M
Earnings Per Share (EPS)-1.75
Cash Flow
In the last 12 months, operating cash flow was -88.22M and capital expenditures -570.00K, giving a free cash flow of -88.80M billion.
Operating Cash Flow-88.22M
Free Cash Flow-88.80M
Free Cash Flow per Share-1.43
Dividends & Yields
Aura Biosciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.11
52-Week Price Change-26.43%
50-Day Moving Average5.95
200-Day Moving Average6.24
Relative Strength Index (RSI)62.13
Average Volume (3m)302.40K
Important Dates
Aura Biosciences Inc upcoming earnings date is Mar 31, 2026, After Close (Confirmed).
Last Earnings DateNov 13, 2025
Next Earnings DateMar 31, 2026
Ex-Dividend Date―
Financial Position
Aura Biosciences Inc as a current ratio of 10.77, with Debt / Equity ratio of 10.37%
Current Ratio10.77
Quick Ratio10.77
Debt to Market Cap0.00
Net Debt to EBITDA0.15
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Aura Biosciences Inc has paid 112.00K in taxes.
Income Tax112.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Aura Biosciences Inc EV to EBITDA ratio is -4.62, with an EV/FCF ratio of -4.88.
EV to Sales0.00
EV to EBITDA-4.62
EV to Free Cash Flow-4.88
EV to Operating Cash Flow-4.95
Balance Sheet
Aura Biosciences Inc has $161.87M in cash and marketable securities with $17.75M in debt, giving a net cash position of $144.11M billion.
Cash & Marketable Securities$161.87M
Total Debt$17.75M
Net Cash$144.11M
Net Cash Per Share$2.32
Tangible Book Value Per Share$3.06
Margins
Gross margin is -23.02%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-23.02%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Aura Biosciences Inc is $19.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$19.33
Price Target Upside195.57% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast―
EPS Growth Forecast-11.41%